HDR Brachytherapy as Monotherapy for Low and Intermediate Risk Prostate Cancer

NCT03424694 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

199

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

RADIATION: HDR brachytherapy as monotherapy

Sponsor

CR-CSSS Champlain-Charles-Le Moyne